For the management of hypertension in the HCV patient, Angiotensin-converting enzyme (ACE) inhibitors should be given only as needed and preferably in combination with sofosbuvir/velpatasvir (SOF/VEL) and not in combination with glecaprevir/pibrentasvir (GLE/PIB)”; “22. Here, ACE is linked to Hypertension.